RXHEALING Trademark

Trademark Overview

On Monday, August 11, 2025, a trademark application was filed for RXHEALING with the United States Patent and Trademark Office. The USPTO has given the RXHEALING trademark a serial number of 99330490. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, August 11, 2025. This trademark is owned by RXHEALING LLC. The RXHEALING trademark is filed in the Advertising, Business and Retail Services category with the following description:

reseller services, namely, distributorship services in the field of wound care devices, remote medical monitoring devices and services, skin grafts, exosomes, and medical devices
rxhealing

General Information

Serial Number99330490
Word MarkRXHEALING
Filing DateMonday, August 11, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, August 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesreseller services, namely, distributorship services in the field of wound care devices, remote medical monitoring devices and services, skin grafts, exosomes, and medical devices

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, August 11, 2025
Primary Code035
First Use Anywhere DateTuesday, July 22, 2025
First Use In Commerce DateTuesday, July 22, 2025

Trademark Owner History

Party NameRXHEALING LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWheatfield, IN 46392

Trademark Events

Event DateEvent Description
Monday, August 11, 2025NEW APPLICATION ENTERED
Monday, August 11, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

rxhealing devices services medical monitoring grafts exosomes remote skin care namely